Your browser doesn't support javascript.
loading
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.
Arulogun, Suzanne O; Brian, Duncan; Goradia, Harshita; Cooney, Aaron; Menne, Tobias; Koo, RayMun; O'Neill, Aideen T; Vos, Josephine M I; Pratt, Guy; Turner, Deborah; Marshall, Kirsty; Manos, Kate; Anderson, Claire; Gavriatopoulou, Maria; Kyriakou, Charalampia; Kersten, Marie J; Minnema, Monique C; Koutoumanou, Eirini; El-Sharkawi, Dima; Linton, Kim; Talaulikar, Dipti; McCarthy, Helen; Bishton, Mark; Follows, George; Wechalekar, Ashutosh; D'Sa, Shirley P.
Afiliação
  • Arulogun SO; University College, London Hospitals NHS Foundation Trust, London, UK.
  • Brian D; Addenbrooke's Hospital, Cambridge, UK.
  • Goradia H; Nottingham University Hospitals, Nottingham, UK.
  • Cooney A; University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK.
  • Menne T; Freeman Hospital, Newcastle Hospitals NHS Foundation Trust, Newcastle, UK.
  • Koo R; Department of Haematology, ACT Pathology, Canberra Health Services, Canberra, Australia.
  • O'Neill AT; University College, London Hospitals NHS Foundation Trust, London, UK.
  • Vos JMI; Department of Hematology & LYMMCARE, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
  • Pratt G; Queen Elizabeth Hospital, Birmingham, UK.
  • Turner D; Torbay and South Devon NHS Foundation Trust, Torbay, UK.
  • Marshall K; The Royal Marsden NHS Foundation Trust, London, UK.
  • Manos K; Austin Health, Melbourne, Australia.
  • Anderson C; Barnet and Chase Farm NHS Hospitals Trust, London, UK.
  • Gavriatopoulou M; Alexandra Hospital, Athens, Greece.
  • Kyriakou C; University College, London Hospitals NHS Foundation Trust, London, UK.
  • Kersten MJ; Department of Hematology & LYMMCARE, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
  • Minnema MC; University Medical Center Utrecht, Utrecht, Netherlands.
  • Koutoumanou E; Great Ormond Street Institute of Child Health, University College London, London, UK.
  • El-Sharkawi D; The Royal Marsden NHS Foundation Trust, London, UK.
  • Linton K; The Christie NHS Foundation Trust, Manchester, UK.
  • Talaulikar D; Department of Haematology, ACT Pathology, Canberra Health Services, Canberra, Australia.
  • McCarthy H; Australian National University Medical School, Canberra, Australia.
  • Bishton M; University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK.
  • Follows G; Translational Medical Sciences, University of Nottingham, Nottingham, UK.
  • Wechalekar A; Addenbrooke's Hospital, Cambridge, UK.
  • D'Sa SP; University College, London Hospitals NHS Foundation Trust, London, UK.
Am J Hematol ; 98(5): 750-759, 2023 05.
Article em En | MEDLINE | ID: mdl-36866925
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article